Edition:
United States

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

3.03USD
16 Feb 2018
Change (% chg)

$0.06 (+2.02%)
Prev Close
$2.97
Open
$3.01
Day's High
$3.04
Day's Low
$2.93
Volume
4,701
Avg. Vol
9,914
52-wk High
$5.25
52-wk Low
$2.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.22 -0.22 -0.22 --
Quarter Ending Jun-18 1 -0.21 -0.21 -0.21 --
Year Ending Dec-18 1 -0.81 -0.81 -0.81 -0.46
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta -- 0.81 0.81
Price to Sales (TTM) -- 6.26 8.57
Price to Book (MRQ) 12.09 4.27 5.14
Price to Tangible Book (MRQ) -- 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions 7.83 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.35 7.30
Sales - 5 Yr. Growth Rate -- 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.45 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago -20.55 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.42
Current Ratio (MRQ) 1.17 3.33 3.38
LT Debt to Equity (MRQ) 0.00 8.98 11.85
Total Debt to Equity (MRQ) 12.02 12.06 15.12
Interest Coverage (TTM) -1.40 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.25 54.90
Gross Margin - 5 Yr. Avg. -- 52.61 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.52 9.86
Operating Margin (TTM) -- 11.43 1.25
Operating Margin - 5 Yr. Avg. -- 14.30 5.07
Pre-Tax Margin (TTM) -- 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -- 14.58 5.33
Net Profit Margin (TTM) -- 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -- 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 919,747,049 819,569,446
Net Income/Employee (TTM) -- 107,578,762 95,804,981
Receivable Turnover (TTM) -- 5.29 5.40
Inventory Turnover (TTM) -- 2.59 3.48
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -229.38 11.11 10.68
Return on Assets - 5 Yr. Avg. -- 12.64 12.00
Return on Investment (TTM) -- 14.00 13.54
Return on Investment - 5 Yr. Avg. -- 16.55 15.72
Return on Equity (TTM) -- 15.34 14.80
Return on Equity - 5 Yr. Avg. -- 17.61 16.91
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -264.31 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.83%
# of Holders: 15
Total Shares Held: 904,935
3 Mo. Net Change: -30,272
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 6
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.